Detalhe da pesquisa
1.
Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.
Cancer
; 119(24): 4223-30, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105075